Invesco Ltd. Cti Biopharma Corp Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$4.2 - $6.01 $1,646 - $2,355	392 Added 1.12%	35,244 $148,000
Q4 2022 Feb 13, 2023	SELL	$4.45 - $6.17 $2.23 Million - $3.1 Million	-502,031 Reduced 93.51%	34,852 $209,000
Q3 2022 Nov 14, 2022	SELL	$5.36 - $7.43 $4.52 Million - $6.26 Million	-843,023 Reduced 61.09%	536,883 $3.13 Million
Q2 2022 Aug 15, 2022	SELL	$3.55 - $6.27 $84,163 - $148,649	-23,708 Reduced 1.69%	1,379,906 $8.24 Million
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $2.67 Million - $7.34 Million	1,403,614 New	1,403,614 $6.56 Million
Q1 2019 May 15, 2019	SELL	$0.9 - $1.37 $15,548 - $23,668	-17,276 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.73 - $2.19 $12,611 - $37,834	17,276 New	17,276 $13,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.